{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:05:43Z","timestamp":1775570743203,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.7759\/cureus.103170","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:26:53Z","timestamp":1770492413000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Lactic Acidosis With Multi-organ Dysfunction Secondary to Terlipressin-Induced Widespread Vasospasm in a Patient With Liver Cirrhosis and Oesophageal Variceal Bleeding: A Case Report"],"prefix":"10.7759","author":[{"given":"Mst","family":"Hiramoti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahin Fardin","family":"Ruthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saqiba","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_23_18","article-title":"Terlipressin-induced ischemic complications: a systematic review of published case reports","volume":"9","author":"Sarma P","year":"2018","unstructured":"Sarma P, Muktesh G, Singh RS, et al.. Terlipressin-induced ischemic complications: a systematic review of published case reports. J Pharmacol Pharmacother. 2018, 9:76-85. 10.4103\/jpp.JPP_23_18","journal-title":"J Pharmacol Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.913150","article-title":"Terlipressin-induced peripheral cyanosis in a patient with liver cirrhosis and hepatorenal syndrome","volume":"20","author":"Chiang CW","year":"2019","unstructured":"Chiang CW, Lin YJ, Huang YB. Terlipressin-induced peripheral cyanosis in a patient with liver cirrhosis and hepatorenal syndrome. Am J Case Rep. 2019, 20:5-9. 10.12659\/AJCR.913150","journal-title":"Am J Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-260","article-title":"The National Early Warning Score 2 (NEWS2)","volume":"19","author":"Smith GB","year":"2019","unstructured":"Smith GB, Redfern OC, Pimentel MA, et al.. The National Early Warning Score 2 (NEWS2). Clin Med (Lond). 2019, 19:260. 10.7861\/clinmedicine.19-3-260","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02816-6","article-title":"A risk score to predict need for treatment for upper-gastrointestinal haemorrhage","volume":"356","author":"Blatchford O","year":"2000","unstructured":"Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000, 356:1318-21. 10.1016\/S0140-6736(00)02816-6","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis EA","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014, 383:1749-61. 10.1016\/S0140-6736(14)60121-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.05.023","article-title":"Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study","volume":"49","author":"Fleming KM","year":"2008","unstructured":"Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol. 2008, 49:732-8. 10.1016\/j.jhep.2008.05.023","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad AA","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al.. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014, 12:145. 10.1186\/s12916-014-0145-y","journal-title":"BMC Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i10.3100","article-title":"Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis","volume":"21","author":"Qi XS","year":"2015","unstructured":"Qi XS, Bao YX, Bai M, Xu WD, Dai JN, Guo XZ. Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis. World J Gastroenterol. 2015, 21:3100-8. 10.3748\/wjg.v21.i10.3100","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013121.pub2","article-title":"Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis","volume":"4","author":"Roccarina D","year":"2021","unstructured":"Roccarina D, Best LM, Freeman SC, et al.. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2021, 4:CD013121. 10.1002\/14651858.CD013121.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v5.i5.251","article-title":"Cirrhotic ascites review: pathophysiology, diagnosis and management","volume":"5","author":"Moore CM","year":"2013","unstructured":"Moore CM, Van Thiel DH. Cirrhotic ascites review: pathophysiology, diagnosis and management. World J Hepatol. 2013, 5:251-63. 10.4254\/wjh.v5.i5.251","journal-title":"World J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s P","year":"2009","unstructured":"Gin\u00e8s P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009, 361:1279-90. 10.1056\/NEJMra0809139","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2009.03.008","article-title":"Portal hypertension and variceal hemorrhage","volume":"93","author":"Sass DA","year":"2009","unstructured":"Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009, 93:837-53. 10.1016\/j.mcna.2009.03.008","journal-title":"Med Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan DE","year":"2024","unstructured":"Kaplan DE, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G, Bosch J. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2024, 79:1180-211. 10.1097\/HEP.0000000000000647","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2020.04.011","article-title":"Evaluation and management of esophageal and gastric varices in patients with cirrhosis","volume":"24","author":"Jakab SS","year":"2020","unstructured":"Jakab SS, Garcia-Tsao G. Evaluation and management of esophageal and gastric varices in patients with cirrhosis. Clin Liver Dis. 2020, 24:335-50. 10.1016\/j.cld.2020.04.011","journal-title":"Clin Liver Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000589","article-title":"Use of wireless capsule endoscopy for the diagnosis and grading of esophageal varices in patients with portal hypertension: a systematic review and meta-analysis","volume":"51","author":"McCarty TR","year":"2017","unstructured":"McCarty TR, Afinogenova Y, Njei B. Use of wireless capsule endoscopy for the diagnosis and grading of esophageal varices in patients with portal hypertension: a systematic review and meta-analysis. J Clin Gastroenterol. 2017, 51:174-82. 10.1097\/MCG.0000000000000589","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155038","article-title":"Multisystem hemodynamic effects of terlipressin in cirrhosis: a scoping review","volume":"87","author":"Skvarce J","year":"2025","unstructured":"Skvarce J, Bui A, Oro P, et al.. Multisystem hemodynamic effects of terlipressin in cirrhosis: a scoping review. J Crit Care. 2025, 87:155038. 10.1016\/j.jcrc.2025.155038","journal-title":"J Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462244-severe-lactic-acidosis-with-multi-organ-dysfunction-secondary-to-terlipressin-induced-widespread-vasospasm-in-a-patient-with-liver-cirrhosis-and-oesophageal-variceal-bleeding-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:26:54Z","timestamp":1770492414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462244-severe-lactic-acidosis-with-multi-organ-dysfunction-secondary-to-terlipressin-induced-widespread-vasospasm-in-a-patient-with-liver-cirrhosis-and-oesophageal-variceal-bleeding-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.103170","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,7]]}}}